Back to company

EPITHERAPEUTICS ApS: Financial statements 2019

CVR: 30523067

EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -198,198 and a net result of DKK 600,267 compared with DKK 1,624,353 the year before. Equity amounted to DKK 33,307,925. The solvency ratio was 99.5%.

Gross Profit
-198,198 kr.
Profit/Loss
600,267 kr.
Equity
33,307,925 kr.
Total Assets
33,461,986 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--198 t.600 t.33.3 mio.-
2018--135 t.1.6 mio.32.7 mio.-
2017--636 t.-35.7 mio.32 mio.-
2016-448 mio.356.4 mio.396.1 mio.-
2015--38.7 mio.-17.1 mio.39.7 mio.11

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

EPITHERAPEUTICS ApS: The 2018 annual report is outJun 12, 2019

EPITHERAPEUTICS ApS has published its annual report for 2018. Gross profit came to DKK -134,510, and the net result was DKK 1,624,353.

About EPITHERAPEUTICS ApS

EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity amounted to DKK 9,205,571.